Clinical Trial Update: Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Decadron (Dexamethasone)
• NINLARO (ixazomib)

Snippet

Sponsor: John L. Reagan | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2021-05-21